台股 » 個股 » 逸達 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

逸達

(6576)
  • 股價
    77.5
  • 漲跌
    ▲0.5
  • 漲幅
    +0.65%
  • 成交量
    191
  • 產業
    上櫃 生技醫療類股▲0.61%
  • 118人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
逸達 (6576)籌碼相關-中國信託-新竹 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

中國信託-新竹 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/3100.00177.5077.50-1186-0.54%
2024/12/3000.00177.8077.70-1186-0.54%
2024/12/27177.5000.0077.7011850.54%
2024/12/2600.00277.0077.80-2183-1.09%
2024/12/19175.6000.0075.9011710.58%
2024/12/1600.00172.8072.90-1164-0.61%
2024/12/0200.00377.0078.50-3137-2.18%
2024/11/2900.00777.7377.00-7133-5.24%
2024/11/281077.7600.0078.00101327.55%
2024/11/2100.00178.7079.40-1108-0.92%
2024/11/14175.80576.0075.80-4104-3.82%
2024/11/11577.4400.0076.7051084.62%
2024/11/0800.00279.4079.30-2107-1.86%
2024/11/01177.4000.0077.9011190.83%
2024/10/17177.5000.0078.7011440.69%
2024/10/08181.0000.0081.4011630.61%
2024/10/07181.9000.0082.3011640.61%
2024/09/30181.9000.0082.5011810.55%
2024/09/24182.3000.0082.2011950.51%
2024/09/2300.00282.1582.20-2201-0.99%
2024/08/0500.00772.7472.50-7299-2.33%
2024/08/02579.50379.5079.5022910.69%
2024/08/01579.9000.0080.4052901.72%
2024/07/2900.00280.1079.50-2289-0.69%
2024/07/2600.002481.7181.30-24286-8.36%
2024/07/23183.00981.7482.10-8287-2.78%
2024/07/2200.001681.2381.60-16287-5.57%
2024/07/1800.002583.2483.20-25280-8.91%
2024/07/15182.9000.0083.4012840.35%
2024/07/12184.5000.0083.4012820.35%
2024/07/11183.7000.0083.4012800.36%
2024/07/10183.400.283.6083.300.82830.28%
2024/07/08584.8000.0084.2052801.78%
2024/07/055.284.9500.0084.705.22781.87%
2024/07/04484.1300.0084.0042741.46%
2024/06/27383.5000.0083.5032691.11%
2024/06/26183.9000.0084.3012660.38%
2024/06/252481.3800.0083.50242609.22%
2024/06/21497.8000.0097.4042241.78%
2024/06/20598.5800.0098.4052232.23%
2024/06/191198.1700.0098.00112244.91%
2024/06/18598.9400.0098.5052212.26%
2024/06/17197.800.397.6098.700.72200.33%
2024/06/141096.3000.0097.10102174.60%
2024/06/1300.00197.4097.00-1222-0.45%
2024/06/1200.002.297.0097.50-2.2223-0.98%
2024/05/2800.000.294.3095.90-0.2239-0.08%
2024/05/2700.000.394.4894.30-0.3241-0.11%
2024/05/200.294.6000.0094.700.22700.06%
2024/05/170.295.1000.0095.000.22860.05%
2024/05/1600.001094.1394.00-10317-3.15%
2024/05/1500.00294.3093.60-2321-0.62%
2024/05/1400.00793.8193.80-7323-2.17%
2024/05/1300.001593.8394.10-15324-4.62%
2024/05/100.294.3900.0094.300.23240.05%
2024/05/09893.8800.0093.8083222.48%
2024/05/07994.1300.0094.4093192.82%
2024/05/03495.8300.0095.7043131.28%
2024/05/02395.9000.0096.0033190.94%
2024/04/300.296.1600.0095.900.23190.08%
2024/04/2910.296.3200.0095.5010.23193.19%
2024/04/1900.005.593.9793.60-5.5339-1.61%
2024/04/1800.00596.9297.00-5329-1.52%
2024/04/1700.001096.8097.00-10331-3.02%
2024/04/162095.9000.0096.80203345.99%
2024/04/1500.00598.4098.30-5331-1.51%
2024/04/1200.006.599.4999.40-6.5331-1.96%
2024/04/1100.002099.5099.40-20331-6.04%
2024/04/100.299.4500.0099.400.23300.05%
2024/04/0900.00599.1099.10-5332-1.50%
2024/04/020.299.4000.0098.000.23300.05%
2024/04/01798.140.398.2098.006.73332.02%
2024/03/2900.00297.6098.00-2334-0.60%
2024/03/2700.000.297.9198.00-0.2363-0.06%
2024/03/26395.6700.0096.6033640.82%
2024/03/25296.7000.0096.9023720.54%
2024/03/22294.9000.0095.5023730.54%
2024/03/21494.4500.0095.0043781.06%
2024/03/200.295.002.195.2094.90-2380-0.51%
2024/03/185.293.5200.0094.505.23791.36%
2024/03/14394.6700.0095.1033710.81%
2024/03/1312.395.0800.0095.7012.33703.31%
2024/03/12295.2000.0096.1023690.54%
2024/03/080.298.42195.0095.70-0.8372-0.21%
2024/03/070.198.5000.0099.000.13620.04%
2024/03/050.1101.000.1102.50100.5003550.01%
2024/03/040.2102.7100.00102.000.23490.07%
2024/02/221.1102.0600.00102.001.13520.32%
2024/02/200.1105.5000.00106.000.13400.04%
2024/02/191.3103.060.3104.00107.0013220.31%
2024/02/0500.001094.9094.40-10282-3.54%
2024/02/02393.5700.0094.0032841.05%
逸達前列腺癌新劑型新藥 確立美國藥證審查完成目標日Anue鉅亨-18天前
逸達營收/去年4.2億、年增115% 今年拚歐、美、中新藥藥證UDN聯合新聞網-23天前
逸達進軍歐盟 首批前列腺癌新劑型新藥正式出貨Anue鉅亨-2024/12/18
逸達 相關文章
逸達 相關影音